메뉴 건너뛰기




Volumn 29, Issue 5, 2015, Pages 1629-1634

Translating dosages from animal models to human clinical trials-revisiting body surface area scaling

Author keywords

Allometric scaling; Allometry; Dose conversion; Interspecies scaling; Pharmacokinetics

Indexed keywords

RESVERATROL; NEW DRUG;

EID: 84932645409     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.14-269043     Document Type: Review
Times cited : (125)

References (64)
  • 1
    • 84867027478 scopus 로고    scopus 로고
    • The determination and interpretation of the therapeutic index in drug development
    • Muller, P. Y., and Milton, M. N. (2012) The determination and interpretation of the therapeutic index in drug development. Nat. Rev. Drug Discov. 11, 751-761
    • (2012) Nat. Rev. Drug Discov. , vol.11 , pp. 751-761
    • Muller, P.Y.1    Milton, M.N.2
  • 3
    • 40449086665 scopus 로고    scopus 로고
    • Dose translation from animal to human studies revisited
    • Reagan-Shaw, S., Nihal, M., and Ahmad, N. (2008) Dose translation from animal to human studies revisited. FASEB J. 22, 659-661
    • (2008) FASEB J. , vol.22 , pp. 659-661
    • Reagan-Shaw, S.1    Nihal, M.2    Ahmad, N.3
  • 5
    • 0035015115 scopus 로고    scopus 로고
    • Body surface area as a determinant of pharmacokinetics and drug dosing
    • Sawyer, M., and Ratain, M. J. (2001) Body surface area as a determinant of pharmacokinetics and drug dosing. Invest. New Drugs 19, 171-177
    • (2001) Invest. New Drugs , vol.19 , pp. 171-177
    • Sawyer, M.1    Ratain, M.J.2
  • 6
    • 0037156937 scopus 로고    scopus 로고
    • How to calculate the dose of chemotherapy
    • Gurney, H. (2002) How to calculate the dose of chemotherapy. Br. J. Cancer 86, 1297-1302
    • (2002) Br. J. Cancer , vol.86 , pp. 1297-1302
    • Gurney, H.1
  • 8
    • 33846115223 scopus 로고    scopus 로고
    • Chemotherapy dosing part I: Scientific basis for current practice and use of body surface area
    • Kaestner, S. A., and Sewell, G. J. (2007) Chemotherapy dosing part I: scientific basis for current practice and use of body surface area. Clin. Oncol. (R Coll Radiol) 19, 23-37
    • (2007) Clin. Oncol. (R Coll Radiol) , vol.19 , pp. 23-37
    • Kaestner, S.A.1    Sewell, G.J.2
  • 9
    • 77950930742 scopus 로고    scopus 로고
    • Of mice and humans: Are they the same-Implications in cancer translational research
    • De Jong, M., and Maina, T. (2010) Of mice and humans: are they the same-Implications in cancer translational research. J. Nucl. Med. 51, 501-504
    • (2010) J. Nucl. Med. , vol.51 , pp. 501-504
    • De Jong, M.1    Maina, T.2
  • 10
    • 70449172754 scopus 로고
    • Quantitative laws in metabolism and growth
    • Von Bertalanffy, L. (1957) Quantitative laws in metabolism and growth. Q. Rev. Biol. 32, 217-231
    • (1957) Q. Rev. Biol. , vol.32 , pp. 217-231
    • Von Bertalanffy, L.1
  • 11
    • 84957355538 scopus 로고
    • Body size and metabolic rate
    • Kleiber, M. (1947) Body size and metabolic rate. Physiol. Rev. 27, 511-541
    • (1947) Physiol. Rev. , vol.27 , pp. 511-541
    • Kleiber, M.1
  • 12
    • 84930819284 scopus 로고    scopus 로고
    • A sceptics view: "Kleiber's Law" or the "3/4 Rule" is neither a law nor a rule but rather an empirical approximation
    • Hulbert, A. (2014) A sceptics view: "Kleiber's Law" or the "3/4 Rule" is neither a law nor a rule but rather an empirical approximation. Systems 2, 186-202
    • (2014) Systems , vol.2 , pp. 186-202
    • Hulbert, A.1
  • 13
    • 18944396944 scopus 로고    scopus 로고
    • Allometric scaling of mammalian metabolism
    • White, C. R., and Seymour, R S. (2005) Allometric scaling of mammalian metabolism. J. Exp. Biol. 208, 1611-1619
    • (2005) J. Exp. Biol. , vol.208 , pp. 1611-1619
    • White, C.R.1    Seymour, R.S.2
  • 14
    • 35349016814 scopus 로고    scopus 로고
    • Application of allometric principles for the prediction of pharmacokinetics in human and veterinary drug development
    • Mahmood, I. (2007) Application of allometric principles for the prediction of pharmacokinetics in human and veterinary drug development. Adv. Drug Deliv. Rev. 59, 1177-1192
    • (2007) Adv. Drug Deliv. Rev. , vol.59 , pp. 1177-1192
    • Mahmood, I.1
  • 15
    • 0014818006 scopus 로고
    • Energy metabolism, body size, and problems of scaling
    • Schmidt-Nielsen, K. (1970) Energy metabolism, body size, and problems of scaling. Fed. Proc. 29, 1524-1532
    • (1970) Fed. Proc. , vol.29 , pp. 1524-1532
    • Schmidt-Nielsen, K.1
  • 16
    • 0001341126 scopus 로고
    • Uber den einfluss der korpergrosse auf stoffund kraftwechsel
    • Rubner, M. (1883) Uber den einfluss der korpergrosse auf stoffund kraftwechsel. Zeit. Biol. 19, 536-562
    • (1883) Zeit. Biol. , vol.19 , pp. 536-562
    • Rubner, M.1
  • 17
    • 0001146529 scopus 로고
    • The use of body surface area as a criterion of drug dosage in cancer chemotherapy
    • Pinkel, D. (1958) The use of body surface area as a criterion of drug dosage in cancer chemotherapy. Cancer Res. 18, 853-856
    • (1958) Cancer Res. , vol.18 , pp. 853-856
    • Pinkel, D.1
  • 18
    • 0343396016 scopus 로고
    • The blood volume of mammals as determined by experiments upon rabbits, guinea pigs, and mice and its relationship to the body weight and to the surface area expressed as a formula
    • Dreyer, G., and Ray, W. (1910) The Blood Volume of Mammals as Determined by Experiments upon Rabbits, Guinea Pigs, and Mice and Its Relationship to the Body Weight and to the Surface Area Expressed as a Formula. Phil. Trans. Royal Soc. London, s. B. 201, 133-60
    • (1910) Phil. Trans. Royal Soc. London, S. B. , vol.201 , pp. 133-160
    • Dreyer, G.1    Ray, W.2
  • 19
    • 33444464475 scopus 로고
    • Further experiments upon the blood volume of mammals and its relation to the surface area of the body
    • Dreyer, G., and Ray, W. (1912) Further Experiments upon the Blood Volume of Mammals and Its Relation to the Surface Area of the Body. Phil. Trans. Royal Soc. London, s. B. 202, 191-212
    • (1912) Phil. Trans. Royal Soc. London, S. B. , vol.202 , pp. 191-212
    • Dreyer, G.1    Ray, W.2
  • 20
    • 0000664818 scopus 로고
    • Body size and metabolism
    • Kleiber, M. (1932) Body size and metabolism. Hilgardia 6, 315-353
    • (1932) Hilgardia , vol.6 , pp. 315-353
    • Kleiber, M.1
  • 22
    • 67549090108 scopus 로고    scopus 로고
    • Blood collection techniques in exotic small mammals
    • Joslin, J. O. (2009) Blood collection techniques in exotic small mammals. J. Exot. Pet Med. 18, 117-139
    • (2009) J. Exot. Pet Med. , vol.18 , pp. 117-139
    • Joslin, J.O.1
  • 26
    • 84859838638 scopus 로고
    • Serum albumin and globulin
    • Walker, H. K., Hall, W. D., and Hurst, J. W., eds., Butterworths, Boston
    • Busher, J. T. (1990) Serum albumin and globulin. In Clinical Methods: The History, Physical, and Laboratory Examinations (Walker, H. K., Hall, W. D., and Hurst, J. W., eds.), pp. 497-499, Butterworths, Boston
    • (1990) Clinical Methods: The History, Physical, and Laboratory Examinations , pp. 497-499
    • Busher, J.T.1
  • 27
    • 84867047842 scopus 로고    scopus 로고
    • Of mice and men: Divergence of gene expression patterns in kidney
    • Cheval, L., Pierrat, F., Rajerison, R., Piquemal, D., and Doucet, A. (2012) Of mice and men: divergence of gene expression patterns in kidney. PLoS ONE 7, e46876
    • (2012) PLoS ONE , vol.7 , pp. e46876
    • Cheval, L.1    Pierrat, F.2    Rajerison, R.3    Piquemal, D.4    Doucet, A.5
  • 28
    • 3042603447 scopus 로고    scopus 로고
    • Kidney mass and relative medullary thickness of rodents in relation to habitat, body size, and phylogeny
    • Al-Kahtani, M. A., Zuleta, C., Caviedes-Vidal, E., and Garland, T., Jr. (2004) Kidney mass and relative medullary thickness of rodents in relation to habitat, body size, and phylogeny. Physiol. Biochem. Zool. 77, 346-365
    • (2004) Physiol. Biochem. Zool. , vol.77 , pp. 346-365
    • Al-Kahtani, M.A.1    Zuleta, C.2    Caviedes-Vidal, E.3    Garland, T.4
  • 29
    • 0032428485 scopus 로고    scopus 로고
    • Applications and limitations of interspecies scaling and in vitro extrapolation in pharmacokinetics
    • Lin, J. H. (1998) Applications and limitations of interspecies scaling and in vitro extrapolation in pharmacokinetics. Drug Metab. Dispos. 26, 1202-1212
    • (1998) Drug Metab. Dispos. , vol.26 , pp. 1202-1212
    • Lin, J.H.1
  • 30
    • 0020963903 scopus 로고
    • Physiologically based pharmacokinetic modeling: Principles and applications
    • Gerlowski, L. E., and Jain, R. K. (1983) Physiologically based pharmacokinetic modeling: principles and applications. J. Pharm. Sci. 72, 1103-1127
    • (1983) J. Pharm. Sci. , vol.72 , pp. 1103-1127
    • Gerlowski, L.E.1    Jain, R.K.2
  • 34
    • 84908178935 scopus 로고    scopus 로고
    • The "genomic storm" induced by bacterial endotoxin is calmed by a nuclear transport modifier that attenuates localized and systemic inflammation
    • DiGiandomenico, A., Veach, R. A., Zienkiewicz, J., Moore, D. J., Wylezinski, L. S., Hutchens, M. A., and Hawiger, J. (2014) The "genomic storm" induced by bacterial endotoxin is calmed by a nuclear transport modifier that attenuates localized and systemic inflammation. PLoS ONE 9, e110183
    • (2014) PLoS ONE , vol.9 , pp. e110183
    • Di Giandomenico, A.1    Veach, R.A.2    Zienkiewicz, J.3    Moore, D.J.4    Wylezinski, L.S.5    Hutchens, M.A.6    Hawiger, J.7
  • 35
    • 58149189408 scopus 로고    scopus 로고
    • Antibodymediated delivery of interleukin-2 to the stroma of breast cancer strongly enhances the potency of chemotherapy
    • Marlind, J., Kaspar, M., Trachsel, E., Sommavilla, R., Hindle, S., Bacci, C., Giovannoni, L., and Neri, D. (2008) Antibodymediated delivery of interleukin-2 to the stroma of breast cancer strongly enhances the potency of chemotherapy. Clin. Cancer Res. 14, 6515-6524
    • (2008) Clin. Cancer Res. , vol.14 , pp. 6515-6524
    • Marlind, J.1    Kaspar, M.2    Trachsel, E.3    Sommavilla, R.4    Hindle, S.5    Bacci, C.6    Giovannoni, L.7    Neri, D.8
  • 37
    • 34548324267 scopus 로고    scopus 로고
    • The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trials
    • Marchetti, S., and Schellens, J. H. (2007) The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trials. Br. J. Cancer 97, 577-581
    • (2007) Br. J. Cancer , vol.97 , pp. 577-581
    • Marchetti, S.1    Schellens, J.H.2
  • 38
    • 84892960440 scopus 로고    scopus 로고
    • Lost in translation: Animal models and clinical trials in cancer treatment
    • Mak, I. W., Evaniew, N., and Ghert, M. (2014) Lost in translation: animal models and clinical trials in cancer treatment. Am. J. Transl. Res. 6, 114-118
    • (2014) Am. J. Transl. Res. , vol.6 , pp. 114-118
    • Mak, I.W.1    Evaniew, N.2    Ghert, M.3
  • 39
    • 0031938243 scopus 로고    scopus 로고
    • Comparative pharmacokinetics of deramciclane in rat, dog, rabbit and man after the administration of a single oral dose of 3 mg kg
    • Klebovich, I., Kanerva, H., Bojti, E., Urtti, A., and Drabant, S. (1998) Comparative pharmacokinetics of deramciclane in rat, dog, rabbit and man after the administration of a single oral dose of 3 mg kg. Pharm. Pharmacol. Commun. 4, 129-136
    • (1998) Pharm. Pharmacol. Commun. , vol.4 , pp. 129-136
    • Klebovich, I.1    Kanerva, H.2    Bojti, E.3    Urtti, A.4    Drabant, S.5
  • 40
    • 33847338002 scopus 로고    scopus 로고
    • Cross-species pharmacokinetic comparison from mouse to man of a second-generation antisense oligonucleotide, ISIS 301012, targeting human apolipoprotein B-100
    • Yu, R. Z., Kim, T. W., Hong, A., Watanabe, T. A., Gaus, H. J., and Geary, R. S. (2007) Cross-species pharmacokinetic comparison from mouse to man of a second-generation antisense oligonucleotide, ISIS 301012, targeting human apolipoprotein B-100. Drug Metab. Dispos. 35, 460-468
    • (2007) Drug Metab. Dispos. , vol.35 , pp. 460-468
    • Yu, R.Z.1    Kim, T.W.2    Hong, A.3    Watanabe, T.A.4    Gaus, H.J.5    Geary, R.S.6
  • 41
    • 0032955949 scopus 로고    scopus 로고
    • The pharmacokinetic principles behind scaling from preclinical results to phase I protocols
    • Mahmood, I., and Balian, J. D. (1999) The pharmacokinetic principles behind scaling from preclinical results to phase I protocols. Clin. Pharmacokinet. 36, 1-11
    • (1999) Clin. Pharmacokinet. , vol.36 , pp. 1-11
    • Mahmood, I.1    Balian, J.D.2
  • 42
    • 0017100591 scopus 로고
    • Problems in extrapolating toxicity data for laboratory animals to man
    • Dixon, R. L. (1976) Problems in extrapolating toxicity data for laboratory animals to man. Environ. Health Perspect. 13, 43-50
    • (1976) Environ. Health Perspect. , vol.13 , pp. 43-50
    • Dixon, R.L.1
  • 43
    • 0014709310 scopus 로고
    • The evaluation of anticancer drugs in dogs and monkeys for the prediction of qualitative toxicities in man
    • Schein, P. S., Davis, R. D., Carter, S., Newman, J., Schein, D. R., and Rall, D. P. (1970) The evaluation of anticancer drugs in dogs and monkeys for the prediction of qualitative toxicities in man. Clin. Pharmacol. Ther. 11, 3-40
    • (1970) Clin. Pharmacol. Ther. , vol.11 , pp. 3-40
    • Schein, P.S.1    Davis, R.D.2    Carter, S.3    Newman, J.4    Schein, D.R.5    Rall, D.P.6
  • 45
    • 34748925493 scopus 로고    scopus 로고
    • Prediction of human pharma-cokinetics using physiologically based modeling: A retrospective analysis of 26 clinically tested drugs
    • De Buck, S. S., Sinha, V. K, Fenu, L. A, Nijsen, M. J., Mackie, C. E., and Gilissen, R A (2007) Prediction of human pharma-cokinetics using physiologically based modeling: a retrospective analysis of 26 clinically tested drugs. Drug Metab. Dispos. 35, 1766-1780
    • (2007) Drug Metab. Dispos. , vol.35 , pp. 1766-1780
    • De Buck, S.S.1    Sinha, V.K.2    Fenu, L.A.3    Nijsen, M.J.4    Mackie, C.E.5    Gilissen, R.A.6
  • 47
    • 33344471951 scopus 로고    scopus 로고
    • Comments on "a mathematical description of the functionality of correction factors used in allometry for predicting human drug clearance"
    • Mahmood, I. (2006) Comments on "a mathematical description of the functionality of correction factors used in allometry for predicting human drug clearance". Drug Metab. Dispos. 34, 507-509
    • (2006) Drug Metab. Dispos. , vol.34 , pp. 507-509
    • Mahmood, I.1
  • 48
    • 84862620957 scopus 로고    scopus 로고
    • Models of physiology and physiologically based models in clinical pharmacology
    • Atkinson, A J., Jr., and Smith, B. P. (2012) Models of physiology and physiologically based models in clinical pharmacology. Clin. Pharmacol. Ther. 92, 3-6
    • (2012) Clin. Pharmacol. Ther. , vol.92 , pp. 3-6
    • Atkinson, A.J.1    Smith, B.P.2
  • 49
    • 77449086999 scopus 로고    scopus 로고
    • Compartmental analysis and its manifold applications to pharmacokinetics
    • Rescigno, A. (2010) Compartmental analysis and its manifold applications to pharmacokinetics. AAPSJ. 12, 61-72
    • (2010) AAPSJ. , vol.12 , pp. 61-72
    • Rescigno, A.1
  • 50
    • 15244344542 scopus 로고    scopus 로고
    • Application of full physiological models for pharmaceutical drug candidate selection and extrapolation of pharmacokinetics to man
    • Parrott, N., Jones, H., Paquereau, N., and Lave, T. (2005) Application of full physiological models for pharmaceutical drug candidate selection and extrapolation of pharmacokinetics to man. Basic Clin. Pharmacol. Toxicol. 96, 193-199
    • (2005) Basic Clin. Pharmacol. Toxicol. , vol.96 , pp. 193-199
    • Parrott, N.1    Jones, H.2    Paquereau, N.3    Lave, T.4
  • 54
    • 80054853722 scopus 로고    scopus 로고
    • Subchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activity
    • Johnson, W. D., Morrissey, R. L., Usborne, A. L., Kapetanovic, I., Crowell, J. A., Muzzio, M., and McCormick, D. L. (2011) Subchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activity. Food Chem. Toxicol. 49, 3319-3327
    • (2011) Food Chem. Toxicol. , vol.49 , pp. 3319-3327
    • Johnson, W.D.1    Morrissey, R.L.2    Usborne, A.L.3    Kapetanovic, I.4    Crowell, J.A.5    Muzzio, M.6    McCormick, D.L.7
  • 58
    • 9444296057 scopus 로고    scopus 로고
    • High absorption but very low bioavailability of oral resveratrol in humans
    • Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., Jr., and Walle, U. K. (2004) High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab. Dispos. 32, 1377-1382
    • (2004) Drug Metab. Dispos. , vol.32 , pp. 1377-1382
    • Walle, T.1    Hsieh, F.2    De Legge, M.H.3    Oatis, J.E.4    Walle, U.K.5
  • 59
    • 0037248470 scopus 로고    scopus 로고
    • Absorption of three wine-related polyphenols in three different matrices by healthy subjects
    • Goldberg, D. M., Yan, J., and Soleas, G. J. (2003) Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin. Biochem. 36, 79-87
    • (2003) Clin. Biochem. , vol.36 , pp. 79-87
    • Goldberg, D.M.1    Yan, J.2    Soleas, G.J.3
  • 60
    • 1242336775 scopus 로고    scopus 로고
    • Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice
    • Meng, X., Maliakal, P., Lu, H., Lee, M. J., and Yang, C. S. (2004) Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice. J. Agric. Food Chem. 52, 935-942
    • (2004) J. Agric. Food Chem. , vol.52 , pp. 935-942
    • Meng, X.1    Maliakal, P.2    Lu, H.3    Lee, M.J.4    Yang, C.S.5
  • 61
    • 0036082463 scopus 로고    scopus 로고
    • Metabolism and disposition of resveratrol in rats: Extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model
    • Marier, J. F., Vachon, P., Gritsas, A., Zhang, J., Moreau, J. P., and Ducharme, M. P. (2002) Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J. Pharmacol. Exp. Ther. 302, 369-373
    • (2002) J. Pharmacol. Exp. Ther. , vol.302 , pp. 369-373
    • Marier, J.F.1    Vachon, P.2    Gritsas, A.3    Zhang, J.4    Moreau, J.P.5    Ducharme, M.P.6
  • 62
    • 20344364428 scopus 로고    scopus 로고
    • Metabolism and bioavailability of trans-resveratrol
    • Wenzel, E., and Somoza, V. (2005) Metabolism and bioavailability of trans-resveratrol. Mol. Nutr. Food Res. 49, 472-481
    • (2005) Mol. Nutr. Food Res. , vol.49 , pp. 472-481
    • Wenzel, E.1    Somoza, V.2
  • 63
    • 53849145999 scopus 로고    scopus 로고
    • The impact of aqueous solubility and dose on the pharmacokinetic profiles of resveratrol
    • Das, S., Lin, H. S., Ho, P. C., and Ng, K. Y. (2008) The impact of aqueous solubility and dose on the pharmacokinetic profiles of resveratrol. Pharm. Res. 25, 2593-2600
    • (2008) Pharm. Res. , vol.25 , pp. 2593-2600
    • Das, S.1    Lin, H.S.2    Ho, P.C.3    Ng, K.Y.4
  • 64
    • 79959910572 scopus 로고    scopus 로고
    • Population pharmacokinetic modeling of trans-resveratrol and its glucuronide and sulfate conjugates after oral and intravenous administration in rats
    • Colom, H., Alfaras, I., Maijó, M., Juan, M. E., and Planas, J. M. (2011) Population pharmacokinetic modeling of trans-resveratrol and its glucuronide and sulfate conjugates after oral and intravenous administration in rats. Pharm. Res. 28, 1606-1621
    • (2011) Pharm. Res. , vol.28 , pp. 1606-1621
    • Colom, H.1    Alfaras, I.2    Maijó, M.3    Juan, M.E.4    Planas, J.M.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.